Speaker illustration

Doctor Nicolas del-Cuerpo-Salinas

UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)

Member of:

European Society of Cardiology

Cardiovascular prevention with GLP1 agonists in high or very-high cardiovascular risk irrespective of diabetes.

Event: ESC Congress 2024

Topic: Secondary Prevention

Session: Obesity and pre-diabetes: where do we stand today on prevention and treatment?

Thumbnail

Heart failure and renal outcomes in patient treated with GLP1 agonists.

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Biomarkers to guide the treatment of heart failure: where are we going?

Thumbnail